Oasis 7 trial clopidogrel - Double-dose versus standard-dose clopidogrel- The Lancet
CURRENT OASIS 7 trial found that double dose clopidogrel was associated with significant reduction in stent thrombosis in those who underwent PCI.
The somewhat conflicting results of CURRENT OASIS 7 have inspired from 7 days of double-dose clopidogrel in 25,086 CURRENT-OASIS 7 trial was
CURRENT-OASIS 7 Published: 2010(Hamilton, Ontario) — The CURRENT-OASIS 7 trial has finally been CURRENT-OASIS 7 Published: Double-Dose Clopidogrel in
CURRENT-OASIS 7: Clopidogrel and aspirin optimal dose Usage in individuals undergoing percutaneous coronary intervention to Reduce RecurrENT events – seventh …
OASIS-7. CURRENT OASIS 7: A 2X2 Factorial Randomized Trial of Optimal Clopidogrel and Aspirin Dosing in Patients with ACS Undergoing …
In the CURRENT-OASIS 7 trial, more than 25,000 patients with ACS for whom an interventional strategy was planned were randomized to either double-dose clopdiogrel (a 600-mg loading dose on the first day followed by 150 mg daily for 6 days and 75 mg daily thereafter) or standard-dose clopidogrel (a